SCM
LOXO

Suffolk Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History

Suffolk Capital Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-41,399
Closed -$7.07M – 152
2018
Q3 		$7.07M Sell
41,399
-5,053
-11% -$849K 1.01% 42
2018
Q2 		$8.06M Buy
46,452
+40,115
+633% +$6.03M 1.15% 42
2018
Q1 		$731K Sell
6,337
-4,300
-40% -$457K 0.1% 107
2017
Q4 		$895K Sell
10,637
-1,600
-13% -$133K 0.12% 80
2017
Q3 		$1.13M Sell
12,237
-721
-6% -$56K 0.15% 98
2017
Q2 		$1.04M Buy
+12,958
New +$718K 0.14% 111

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Suffolk Capital Management's LOXO Position: Q4 2018 in Review

Suffolk Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 41,399 shares — an estimated $7.07M sold.

Suffolk Capital Management first reported a position in LOXO in Q2 2017 and held it in 6 quarters. The position peaked at $8.06M in Q2 2018. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

  • Suffolk Capital Management reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
  • Suffolk Capital Management sold 41,399 Loxo Oncology, Inc shares in Q4 2018, an estimated $7.07M.
  • Suffolk Capital Management first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 6 quarters.
  • Suffolk Capital Management's Loxo Oncology, Inc position peaked at $8.06M in Q2 2018.
  • 232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on Suffolk Capital Management's 13F filing for Q4 2018, filed 23 Jan 2019.